Christopher Do

Q: What is Christopher Do email address?

Email Christopher Do at christopher.do@bms.com. This email is the most updated Christopher Do email found in 2026.

Q: How to contact Christopher Do?

To contact Christopher Do send an email to christopher.do@bms.com. (updated on October 30, 2024)

Senior Principal Scientist at Bristol Myers Squibb | Bellevue, Washington, United States

About Christopher Do

Christopher Do is a Senior Principal Scientist at Bristol Myers Squibb, where he leverages over a decade of post-doctoral experience in translational research and immunoassay development to drive innovation in the field of cellular therapy. His current role focuses on analytical development, where he plays a pivotal part in shaping impurity strategies and overseeing method qualifications and transfers. This expertise is crucial in ensuring the safety and efficacy of novel therapeutics, particularly in the rapidly evolving landscape of cell-based treatments.

Christopher's proficiency in analytical method validation and multiplexing techniques allows him to develop robust assays that are essential for bioanalytical purposes. His work often involves the application of ELISA and other immunoassays to quantify therapeutic agents and their impurities, ensuring compliance with regulatory standards. His strategic planning skills enable him to navigate complex project requirements, making him a key contributor to cross-functional teams that aim to accelerate product development timelines.

In addition to his technical skills, Christopher's adaptability and collaborative spirit allow him to thrive in fast-paced environments, effectively "sitting in any seat on the bus." This versatility is vital in the dynamic field of biotechnology, where he frequently engages with various stakeholders, from research and development to regulatory affairs. His commitment to advancing life sciences through innovative analytical solutions positions him as a thought leader in the industry, driving forward the mission of Bristol Myers Squibb to deliver transformative therapies to patients in need.

Christopher Do Work